TP53 and rectal cancer: Associated with decreased rectal cancer risk overall (OR = 0.68; 95% CI: 0.27–1.73) and specifically with rectal tumors bearing a TP53 mutation (OR = 0.66; 95% CI: 0.46–0.94)